Image

Natural History Study of Synucleinopathies

Study on progression of synuclein-related conditions.

Recruiting
18 years and older
All
Phase N/A

Synucleinopathies are rare diseases where the body has too much of a protein called α-synuclein in the nervous system. This can cause problems like moving slowly, trouble with coordination, or memory issues. These diseases usually start in people over 50 years old. Common types are Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). Sometimes, the first signs happen outside the brain, such as trouble with digestion, urination, or blood pressure, before affecting the brain. The study aims to learn how synucleinopathies change over time and find clues to predict who might develop further problems.

  • The study involves follow-up visits at various centers.
  • Participants must be 18 or older and have specific symptoms.
  • Excludes those with conditions like diabetes, heart failure, or drug-related issues.
Study details
    Patients With Synucleinopathies
    Neurogenic Orthostatic Hypotension
    Pure Autonomic Failure
    REM Sleep Behavior Disorder
    Parkinson Disease
    Dementia With Lewy Bodies
    Multiple System Atrophy
    Shy-Drager Disease

NCT01799915

NYU Langone Health

17 April 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.